Delyon J - Search Results

1

Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series.

Lemasson J, Cuzzubbo S, Doucet L, Gounant V, Baroudjian B, Herms F, Carpentier AF, Lebbé C, Vitaux H, Hautefort C, Delyon J; PATIO group. Lemasson J, et al. Among authors: delyon j. Eur J Cancer. 2019 Aug;117:116-118. doi: 10.1016/j.ejca.2019.05.022. Epub 2019 Jul 3. Eur J Cancer. 2019. PMID: 31279302 No abstract available.

2

[Clinical and biological heterogeneity of melanomas].

Delyon J, Mourah S, Lebbé C. Delyon J, et al. Rev Prat. 2014 Jan;64(1):72-3. Rev Prat. 2014. PMID: 24649551 Review. French. No abstract available.

3

EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells.

Delyon J, Khayati F, Djaafri I, Podgorniak MP, Sadoux A, Setterblad N, Boutalbi Z, Maouche K, Maskos U, Menashi S, Lebbé C, Mourah S. Delyon J, et al. Exp Dermatol. 2015 Jun;24(6):443-8. doi: 10.1111/exd.12693. Epub 2015 Apr 16. Exp Dermatol. 2015. PMID: 25807898

4

The ipilimumab lesson in melanoma: achieving long-term survival.

Delyon J, Maio M, Lebbé C. Delyon J, et al. Semin Oncol. 2015 Jun;42(3):387-401. doi: 10.1053/j.seminoncol.2015.02.005. Epub 2015 Feb 17. Semin Oncol. 2015. PMID: 25965357 Review.

5

Validation of a preclinical model for assessment of drug efficacy in melanoma.

Delyon J, Varna M, Feugeas JP, Sadoux A, Yahiaoui S, Podgorniak MP, Leclert G, Dorval SM, Dumaz N, Soulie J, Janin A, Mourah S, Lebbé C. Delyon J, et al. Oncotarget. 2016 Mar 15;7(11):13069-81. doi: 10.18632/oncotarget.7541. Oncotarget. 2016. PMID: 26909610 Free PMC article.

6

STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network.

Delyon J, Chevret S, Jouary T, Dalac S, Dalle S, Guillot B, Arnault JP, Avril MF, Bedane C, Bens G, Pham-Ledard A, Mansard S, Grange F, Machet L, Meyer N, Legoupil D, Saiag P, Idir Z, Renault V, Deleuze JF, Hindie E, Battistella M, Dumaz N, Mourah S, Lebbe C; GCC (French Group of Skin Cancer). Delyon J, et al. J Invest Dermatol. 2018 Jan;138(1):58-67. doi: 10.1016/j.jid.2017.07.839. Epub 2017 Aug 24. J Invest Dermatol. 2018. PMID: 28843487 Free article. Clinical Trial.

7

Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors.

Arangalage D, Delyon J, Lermuzeaux M, Ekpe K, Ederhy S, Pages C, Lebbé C. Arangalage D, et al. Among authors: delyon j. Ann Intern Med. 2017 Nov 7;167(9):683-684. doi: 10.7326/L17-0396. Epub 2017 Sep 5. Ann Intern Med. 2017. PMID: 28869988 No abstract available.

8

Transient pituitary ACTH-dependent Cushing syndrome caused by an immune checkpoint inhibitor combination.

Lupu J, Pages C, Laly P, Delyon J, Laloi M, Petit A, Basset-Seguin N, Oueslati I, Zagdanski AM, Young J, Bouche C, Lebbé C, Gautier JF. Lupu J, et al. Among authors: delyon j. Melanoma Res. 2017 Dec;27(6):649-652. doi: 10.1097/CMR.0000000000000405. Melanoma Res. 2017. PMID: 29036015

9

PD-1 blockade with nivolumab in endemic Kaposi sarcoma.

Delyon J, Bizot A, Battistella M, Madelaine I, Vercellino L, Lebbé C. Delyon J, et al. Ann Oncol. 2018 Apr 1;29(4):1067-1069. doi: 10.1093/annonc/mdy006. Ann Oncol. 2018. PMID: 29324995 Free article. No abstract available.

10

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors.

Roger A, Groh M, Lorillon G, Le Pendu C, Maillet J, Arangalage D, Tazi A, Lebbe C, Baroudjian B, Delyon J; PATIO group. Roger A, et al. Among authors: delyon j. Ann Rheum Dis. 2019 Aug;78(8):e82. doi: 10.1136/annrheumdis-2018-213857. Epub 2018 Jun 23. Ann Rheum Dis. 2019. PMID: 29936437 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page